Where does Scipher Medicine Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Scipher Medicine Corporation ranks #37,373 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Scipher Medicine Corporation hold?

Scipher Medicine Corporation holds 7 US utility patents granted between 2021 and 2024, spanning 8 technology areas.

What is Scipher Medicine Corporation's Innovation Score?

Scipher Medicine Corporation has an Innovation Score of 46.9 out of 100 (top 20% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Scipher Medicine Corporation's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Scipher Medicine Corporation.

What does claim depth mean for Scipher Medicine Corporation's patents?

Scipher Medicine Corporation's patents average 21.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Scipher Medicine Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Scipher Medicine Corporation

Q: What technology areas does Scipher Medicine Corporation focus on?

Scipher Medicine Corporation's top technology area is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data) with 7 patents. Grants appear in 8 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 8 technology areas, recorded in grant years 2021–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Scipher ranks #37,373 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 8 technology areas.

#37,373
of 49,997 US assignees by volume: Top 20%
by Innovation Score (46.9/100): 21.7
avg claims per patent

USPTO PatentsView assignee plate

Corpus R37373 · US Corporation #37,373 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #37,373/49,997
PHOTO-FINISH Schur Technology A/S
CPC-NARROW G16H · 8 areas
INNOV-PAR 46.9/100
CLAIMS-DENSE 21.7 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2024 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Schur Technology A/S (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Scipher Medicine · this assignee

47
3D Lighting… · lowest

7

What this shows Scipher's Innovation Score is 46.9/100 (top 20% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Scipher's grants concentrate

Scipher Medicine Corporation is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2022. By volume, Scipher sits between Schur Technology A/S and SDC Technologies, Inc..

Scipher's three-year grant acceleration

Scipher Medicine Corporation shows 5 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Schur Technology…

7
Schwihag

7
Scidatek

7
Scientech

7
Scodix

7
Scramoge Technolo…

7
SD3

7
SDC

7
Scipher Medicine ◀

7

What this shows Scipher holds 7 patents at rank #37,323, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Scipher

By rank, the assignees closest to #37,323 in granted patent volume.

Leaders in G16H (Healthcare Informatics)

Other assignees with the most granted patents in Scipher's primary technology class.

Scipher's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 20% higher than 80% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Scipher Medicine Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	2	28.6%
2022	1	14.3%
2023	1	14.3%
2024	3	42.9%

Which technologies does Scipher Medicine Corporation patent most?

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 7

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 6

C07K - Peptides 6

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

G06N - Computing Arrangements Based ON Specific Computational Models 1

Top 8 of 8 technology areas

Where it ranks

Overall rank by patents

#37,373

of 49,997 tracked assignees

Innovation Score

46.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Scipher Medicine Corporation's patent record in context - here's where to go next.

Scipher Medicine Corporation's lead technology class is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data), 100% of its portfolio - see every assignee active in that class. Explore G16H
Ranked #37,373 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Scipher Medicine Corporation against Schur Technology A/S, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.